Cargando…

Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521951/
https://www.ncbi.nlm.nih.gov/pubmed/31305693
http://dx.doi.org/10.1097/MD.0000000000007644
_version_ 1783252073115025408
collection PubMed
description
format Online
Article
Text
id pubmed-5521951
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-55219512017-07-31 Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum Medicine (Baltimore) Erratum Wolters Kluwer Health 2017-07-21 /pmc/articles/PMC5521951/ /pubmed/31305693 http://dx.doi.org/10.1097/MD.0000000000007644 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Erratum
Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum
title Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum
title_full Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum
title_fullStr Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum
title_full_unstemmed Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum
title_short Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum
title_sort marked response to nab-paclitaxel in egfr mutated lung neuroendocrine carcinoma: a case report: erratum
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521951/
https://www.ncbi.nlm.nih.gov/pubmed/31305693
http://dx.doi.org/10.1097/MD.0000000000007644